Reuters
04 Aug 2026, 22:45 UTC · 3h ago
DaVita flags lower revenue per treatment, reaffirms annual forecast
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Search tags
Reuters
04 Aug 2026, 22:45 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Search tags
What the story claims
2 claims · each scored for market impact
DaVita reported lower revenue per treatment in the second quarter. — A decline in per-unit revenue directly impacts top-line growth and profit margins.
-0.60Dialysis treatment enrollments declined as patients left Obamacare plans after pandemic-era subsidies ended. — Loss of patient volume due to structural changes in insurance coverage suggests a persistent headwind for demand.
-0.40Which stocks this story touches
The company reported lower revenue per treatment due to declining dialysis enrollments.
Continue reading
5 related stories
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1d ago
